Login

Switch On Your HIV Smarts.

51% reduction in San Francisco HIV infections since 2012

51% reduction in San Francisco HIV infections since 2012

, by Emily Newman

The number of HIV infections in San Francisco continues to decline, but disparities remain among people who are homeless, people who use drugs, African Americans and Latinos. Read More

Men on PrEP & HIV-positive men are getting hepatitis C during sex—here’s why

Men on PrEP & HIV-positive men are getting hepatitis C during sex—here’s why

, by Emily Newman

The hepatitis C virus can live in rectal fluid and semen, which is why it can be transmitted during sex. Read More

Surprising price break for newly-approved hepatitis C drug

Surprising price break for newly-approved hepatitis C drug

, by Liz Highleyman

Two new hepatitis C cure drugs, Mavyret and Vosevi, have been approved by the FDA—offering a shorter course of treatment, for a lower cost. Read More

Long-acting antiretrovirals for HIV treatment and PrEP

Long-acting antiretrovirals for HIV treatment and PrEP

, by Liz Highleyman

At the recent IAS 2017 conference, we got good news about the safety and efficacy of a long-acting antiretroviral injection and a drug in a new class of medications. Read More

Do you know U=U?

Do you know U=U?

, by Emily Newman

Advocates for “Undetectable=Untransmittable” (U=U) were out, proud and visible this year at the International AIDS Conference, spreading the message that people living with HIV with undetectable viral loads do not transmit HIV to partners. Read More